News | News By Subject | News by Disease News By Date | Search News

Osteoporosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Amgen (AMGN) Faces Setback as Osteoporosis Drug is Linked to Serious Heart Side Effects     5/23/2017
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Showed Significant Results in Phase III Study     9/19/2016
Merck & Co. (MRK) Terminates Development of Osteoporosis Drug Due to Stroke Risk     9/2/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Tops Teriparatide in Phase III Osteoporosis Study     4/4/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Romosozumab Shines in Phase III Osteoporosis Trial     3/21/2016
Amgen (AMGN), UCB Group (UCBJF.PK)'s Osteoporosis Drug Comes Through in Late-Stage Study     2/22/2016
Amgen (AMGN)'s Bone Drug Romosozumab Succeeds In Phase III Study     9/3/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Amgen (AMGN) Tells Analysts It Will Improve Margins 15% By Axing 4,000 Jobs     10/28/2014
Merck & Co. (MRK)'s Long-Delayed Osteoporosis Drug Passes Trial     9/17/2014
Analyst: Safety Worries Dog Merck & Co. (MRK)’s Osteoporosis Drug     9/16/2014
Amgen (AMGN) Spends $270 Million To Exit Osteporosis Pact With GlaxoSmithKline (GSK)     4/4/2014
Radius Bubbles Through Three CEOs, As Osteoporosis Drug Delayed     12/20/2013
Pfizer Inc. (PFE), Ligand Pharmaceuticals Inc. (LGND)'s Hot-Flash, Osteoporosis Drug Duavee Gets FDA Approval     10/7/2013

News from Around the Web
High-Impact Exercise Strengthens Men's Bones, University Of Missouri-Columbia College Of Human Environmental Sciences Study     2/24/2016
Hopping Could Reduce Fracture Risk For Older People, Loughborough University Study     9/14/2015
Exercise Could Reverse Bone Loss In Middle-Aged Men, University of Missouri Study     7/15/2015
Potassium Salts Aid Bone Health, Prevent Osteoporosis, University of Surrey Research Finds     1/15/2015
Drinking Red Wine May Help Treat Osteoporosis, Aarhus University Study     10/20/2014
Why Men Are The Weaker Sex When It Comes To Bone Health, Monash University Study     10/9/2014
Engineering A Better Way To Rebuild Bone Inside The Body, Georgia Institute of Technology Study     5/30/2014
Melatonin May Make Old Bones Stronger, McGill University Study     5/28/2014
Sleep Apnea May Up Osteoporosis Risk, Chi Mei Medical Center Study     4/16/2014
Obesity Tied to Osteoporosis Risk, Harvard University Study     7/16/2013
Osteoporosis Drug Stops Growth Of Breast Cancer Cells, Even In Resistant Tumors, Duke Cancer Institute Study     6/18/2013
Men With Belly Fat at Risk for Osteoporosis, Massachusetts General Hospital Study     11/28/2012
Study Links Osteoporosis Drugs With Fractures, Linkoping University Reveals     5/5/2011
Low Risk of Jaw Problems With Oral Osteoporosis Drugs, University of Pennsylvania Study     3/18/2011
Gene Responsible for Severe Osteoporosis Disorder Discovered, King's College London Study     3/7/2011

Press Releases
Radius Health (RDUS)'s Osteoporosis Drug Meets All Primary and Secondary Endpoints in Phase III Test     5/25/2017
Centrexion To Present Data On CNTX-4975 For The Treatment Of Chronic Pain Associated With Morton’s Neuroma And Knee Osteoarthritis At American Pain Society 2017 Annual Scientific Meeting     5/10/2017
FDA Approves Radius Health (RDUS)’s TYMLOS (Abaloparatide), A Bone Building Agent For The Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture     4/28/2017
Vexim: New Product Launch In Germany: MASTERFLOW PLUS, A New Product Targeted At Low Energy Osteoporotic Fractures     4/18/2017
Radius Health (RDUS) Release: New Analysis from ACTIVE Showed Consistent Fracture Reductions for Abaloparatide-SC Across Geographies     4/3/2017
Radius Health (RDUS) Falls on PDUFA Extension for Abaloparatide-SC     3/10/2017
Safe Orthopaedics, SA Offers New Technologies To Treat Traumatic Injuries Due To Osteoporosis Or Bone Metastases     2/15/2017
Radius Health (RDUS) Release: Mayo Clinic Proceedings Publishes Positive Results From The Activextend Clinical Trial Of Abaloparatide-SC In Postmenopausal Women With Osteoporosis     2/1/2017
Experimental Biology and Medicine Release: Candidate Biomarkers For Postmenopausal Osteoporosis     1/27/2017
Amgen (AMGN) And UCB, Inc. (UCBJF.PK) Announce Submission Of Application For Investigational Osteoporosis Medication Romosozumab In Japan     12/20/2016
Antares Pharma (ATRS) Announces The Successful Completion Of Teva (TEVA)’s Decentralized Procedure For Teriparatide Injection In Europe     12/19/2016
Radiological Society of North America (RSNA) Release: Obesity In Adolescence May Cause Permanent Bone Loss     11/21/2016
Amgen (AMGN) Release: Results From Phase 3 BRIDGE Study Show Romosozumab Significantly Increases Bone Mineral Density In Men With Osteoporosis     11/14/2016
Bone Index Has Obtained Exclusive Rights In U.S. For Bindex - World's First Pocket-sized Diagnostic Device For Osteoporosis     11/11/2016
TAmiRNA Release: osteomiR: Worldwide First miRNA-based Test For Early Detection Of Osteoporosis     9/19/2016